GLP-1 increased the expression of mRNA and transcription factors that play a part in the pleiotropic effects such as DNA synthesis in pancreatic beta cells, metabolic enzyme gene expression, and insulin biosynthesis
Patients expecting dramatic scale changes in the first month are often disappointed, and this expectation gap is a common reason for early discontinuation
A consistent upward trend, even within the "normal" range, warrants attention because bupropion can cause gradual blood pressure elevation that does not trigger alarm on any single reading but becomes concerning over weeks
"Efficacy and safety of cagrilintide for weight management: A randomized phase 2 trial." Obesity , 31(3), 687-699
This indication can unlock coverage pathways that weight management alone cannot, including Medicare Part D, which now covers at least one anti-obesity medication under the Treat and Reduce Obesity Act effective April 2026
Sinergia para resultados visibles